谷氨酰胺提取分离研究

谷氨酰胺是一种十分有用的氨基酸,它既可作为治疗药物,又可作为其它合成药物的前体。目前国内以谷氨酸为原料,采用化学合成法生产谷氨酰胺,供作试剂用,产量十分有限。日本用发酵法生产谷氨酰胺,年产1000吨,还有增加趋势。谷氨酰胺的销售价格比较高,经济效益可观。近年来国内有好几个研究小组都在进行谷氨酰胺发酵研究。我们是国内第一个谷氨酰胺研究组,已在5m~3发酵罐上取得中试成功。谷氨酰胺发酵液中混有谷氨酸,而这些少量的谷氨酸采用等电点沉淀法并不能将它们去除,影响谷氨酰胺的纯度。我们采用离子交换树脂法,成功地将谷氨酸从谷氨酰胺和谷氨酸的混合物中分离掉,得到单一的谷氨酰胺。在将发酵液上柱交换之前,必须对发酵液进行预处理,我们试验了4种不同方法,结果表明第4种方法更适合工厂使用。从我们使用过的几种树脂的分离效果及树脂的价格看,考虑到工     

课堂教学随笔:谷氨酰胺的氨基

氨基代谢是《生物化学》中"氨基酸代谢"教学的重要内容,谷氨酰胺氨基的去向和利用是其中的重点之一。谷氨酰胺既有α-氨基又有酰胺基,其代谢由不同的酶分别催化,涉及转氨酶、酰胺基转移酶、谷氨酰胺酶、转谷氨酰胺酶等。不同代谢酶作用的基团和机理不同,学生容易混淆它们的作用。本文拟通过讨论几种谷氨酰胺氨基相关代谢酶的作用特点,指导学生掌握谷氨酰胺氨基的代谢。     

谷氨酰胺在肠道的代谢及其对肠粘膜的保护作用

谷氨酰胺是一种十分重要的具有特殊营养作用的条件必需氨基酸。肠道是消耗谷氨酰胺的主要器官。肠粘膜细胞既可利用从肠腔食糜中摄取的谷氨酰胺,也利用从血液中摄取的谷氨酰胺。谷氨酰胺是肠粘膜细胞的主要能源物质,提供氮质参与细胞核酸和蛋白质合成代谢,促进粘膜细胞更新再生。机体谷氨酰胺缺乏,可导致肠粘膜萎缩。在严重创伤、烧伤、感染、恶性肿瘤等病理状态下,补充外源性谷氨酰胺,可维持和恢复肠粘膜的代谢、结构和功能,防止肠道细菌和毒素移位,减轻应激代谢反应。     

谷氨酰胺高效酶法转化条件研究

谷氨酰胺合成酶是生物体氮代谢的中心酶之一,在消耗ATP的情况下,谷氨酰胺合成酶催化由谷氨酸和NH4+向谷氨酰胺的转化,Toch ikura提出了将酵母发酵与纯化酶结合生产谷氨酰胺(G ln)的方法,本实验通过建立酶法合成L-G ln与酵母酒精发酵的能量偶联体系,研究了在此偶联体系中各因素对谷氨酰胺酶转化效率的影响,为工业上利用酶法生产G ln提供理论依据。     

L-谷氨酰胺精制纯化技术研究

研究了将谷氨酰胺粗晶进一步精制纯化使其达到国外质量标准要求的方法,报道了对粗晶谷氨酰胺的脱色条件,粗晶谷氨酰胺溶解液上离子交换树脂柱分离的操作技术和用乙醇析晶后得到的纯品谷氨酰胺的质量情况。     

谷氨酰胺对微囊化重组CHO细胞生长代谢及内皮抑素表达的影响

微囊化技术是一种有发展潜力的生物技术,在细胞移植和药物控释等方面具有广泛的应用。然而由于目前微囊化细胞规模化培养技术还不成熟,阻碍了其在临床治疗中的推广与应用。为了了解微囊化重组CHO细胞的生长代谢特性为今后规模化培养优化提供技术参考,考察了主要氮源物质谷氨酰胺对微囊化重组CHO细胞生长代谢及内皮抑素表达的影响。结果显示:当谷氨酰胺起始浓度从2.69mmolL增加到9.05mmolL时最大活细胞密度并没有增高,细胞增殖没有显著差异。当谷氨酰胺起始浓度较低(2.69mmolL)时,葡萄糖的比消耗速率较大;当谷氨酰胺起始浓度增高时(7.91mmolL～9.05mmolL)葡萄糖和谷氨酰胺的比消耗速率增大,但细胞对葡萄糖和谷氨酰胺的利用率降低。谷氨酰胺对产物表达有显著影响,起始浓度为4.97mmolL时的内皮抑素累积浓度最高,达546.36ngmL,过低和过高谷氨酰胺起始浓度下内皮抑素的累积浓度均较低。     

L—谷氨酸的综合利用 Ⅱ报:从L—谷氨酸合成N—乙酰—L—谷氨酰胺~#

<正> N—乙酰—L—谷氨酰胺(N—Acetyl—L—Glutamine)为L—谷氨酰胺的乙酰化衍生物。具有抗痉挛活性。它比L—谷氨酰胺更易透过“血脑屏障”。改善脑的功能以维持其良好应激机能。适用于肝昏迷及脑外伤、脑肿瘤、神经外科手术等引起的昏迷等。并可调整变态代谢,在体内不会很快消     

微生物谷氨酰胺转胺酶研究进展

微生物谷氨酰胺转胺酶是一种在食品、医药、纺织、化妆品等领域具有广泛应用前景的酶制剂。就其理化性质、作用机理、工业化生产、在食品工业上的应用及当前国内外研究热点进行了概述。并讨论了微生物谷氨酰胺转胺酶在我国生产及应用中存在的问题和困难,对未来的研究方向做出展望。     

不同时间睡眠剥夺对大鼠运动能力及谷氨酰胺的影响

目的：探索睡眠剥夺对大鼠运动能力及谷氨酰胺含量变化的影响,为睡眠剥夺后的运动训练等提供一定的实验依据。方法：将30只雄性SD大鼠按体重随机分安静对照组、0h睡眠剥夺力竭运动组（SDE）、24h SDE、48h SDE和72h SDE组（n=6）,采用轻柔刺激法建立睡眠剥夺模型和依据Bedford建立的大鼠运动模型。结果：24h SDE睡眠剥夺组与0h SDE组比较。大鼠后蹬跑时间明显长（P〈0．05）,48h SDE睡眠剥夺组和72h SDE睡眠剥夺与0h SDE睡眠剥夺组比较,后蹬跑时间显著性减少（P〈0．01）;24h SDE睡眠剥夺组与c组比较大鼠胸腺谷氨酰胺含量显著升高（P〈0．05）,48h SDE睡眠剥夺组和72h SDE睡眠剥夺组与C组比较大鼠胸腺谷氨酰胺含量降低（P〈0．01）;睡眠剥夺组与C组比较,血清谷氨酰胺含量的变化均具有高度显著性差异（P〈0．01）,睡眠剥夺24h后血清谷氨酰胺含量显著增多,却在睡眠剥夺48h、72h后血清谷氨酰胺含量明显下降。结论：①睡眠剥夺24h能提高大鼠运动能力,睡眠剥夺48h甚至是72h后大鼠运动能力开始降低。②睡眠剥夺24h后大鼠胸腺谷氨酰胺含量和血清谷氨酰胺含量升高,而睡眠剥夺48h后大鼠胸腺和血清的谷氨酰胺含量下降明显,睡眠剥夺72h后胸腺和血清谷氨酰胺含量显著性降低。     

淋巴肉瘤组织中谷氨酰胺酶的性质以及谷氨酰胺衍生物对此酶活性的抑制作用

(1) 本文比较了正常胸腺和胸腺淋巴肉瘤线粒体内谷氨酰胺酶的动力学观察,结果发现二者对于谷氨酰胺酶的最适pH、K_M以及对抑制剂和激活剂的作用等都很相近,说明两种组织的谷氨酰胺酶可能具有相似的活性中心。二者对于所试的六种不同的谷氨酰胺衍生物都没有活性。(2) 在所试过的六种谷氨酰胺衍生物中,以N-邻苯二甲酰谷氨酰胺对肉瘤180和肝癌的谷氨酰胺酶活性的抑制作用最为显著,此种抑制可能与该化合物对肿瘤生长的抑制作用有关。(3) N-邻苯二甲酰谷氨酰胺对肉瘤180谷氨酰胺酶活性呈反竞争性抑制作用。     

Simulation of cellular compaction and internalization in mammalian embryo development—II. Models for spherical embryos

A model based upon minimization of surface energy as an explanation for the phenomena of compaction and internalization of cells during mammalian embryo development is generalized for three-dimensional cells. It is shown that, for a spherical embryo, if cells are assumed to be polygonal cones in shape, the simulation of these phenomena for three-dimensional cells is equivalent to simulations of deformations of two-dimensional cells on the surface of a sphere. This equivalence is used to show that in the optimal compacted structure, with no internal cells, the cross-sections of cells in general are not regular polyhedra. Further, the internalization occurs when the number of cells exceeds a critical value which seems to depend on the relative sizes and biophysical properties of cells.     

Varicella-zoster virus glycoprotein I is essential for growth of virus in Vero cells.

Varicella-zoster virus (VZV) encodes at least six glycoproteins. Glycoprotein I (gI), the product of open reading frame 67, is a 58- to 62-kDa glycoprotein found in VZV-infected cells. We constructed two VZV gI deletion mutants. Immunoprecipitation of VZV gE from infected cells indicated that cells infected with VZV deleted for gI expressed a gE that was larger (100 kDa) than that expressed in cells infected with the parental virus (98 kDa). Cell-associated or cell-free VZV deleted for gI grew to lower titers in melanoma cells than did parental VZV. While VZV deleted for gI replicated in other human cells, the mutant virus replicated to very low titers in primary guinea pig and monkey cells and did not replicate in Vero cells. When compared with the parental virus, rescued viruses, in which the gI deletion was restored with a wild-type allele, showed a similarly sized gE and comparable growth patterns in melanoma and Vero cells. VZV deleted for gI entered Vero cells; however, viral DNA synthesis was impaired in these cells. The VZV gI mutant was slightly impaired for adsorption to human cells. Thus, VZV gI is required for replication of the virus in Vero cells, for efficient replication of the virus in nonhuman cells, and for normal processing of gE.     

Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis

Depletion of B cells in rheumatoid arthritis is therapeutically efficacious. Yet, the mechanism by which B cells participate in the inflammatory process is unclear. We previously demonstrated that Ag-specific B cells have two important functions in the development of arthritis in a murine model of rheumatoid arthritis, proteoglycan (PG)-induced arthritis (PGIA). PG-specific B cells function as autoantibody-producing cells and as APCs that activate PG-specific T cells. Moreover, the costimulatory molecule CD86 is up-regulated on PG-specific B cells in response to stimulation with PG. To address the requirement for CD80/CD86 expression on B cells in the development of PGIA, we generated mixed bone marrow chimeras in which CD80/CD86 is specifically deleted on B cells and not on other APC populations. Chimeras with a specific deficiency in CD80/CD86 expression on B cells are resistant to the induction of PGIA. The concentration of PG-specific autoantibody is similar in mice sufficient or deficient for CD80/86-expressing B cells, which indicates that resistance to PGIA is not due to the suppression of PG-specific autoantibody production. CD80/86-deficient B cells failed to effectively activate PG-specific autoreactive T cells as indicated by the failure of T cells from PG-immunized CD80/86-deficient B cell chimeras to transfer arthritis into SCID mice. In vitro secondary recall responses to PG are also dependent on CD80/86-expressing B cells. These results demonstrate that a CD80/86:CD28 costimulatory interaction between B cells and T cells is required for autoreactive T cell activation and the induction of arthritis but not for B cell autoantibody production.     

BCLW mediates survival of postmitotic Sertoli cells by regulating BAX activity.

Male mice deficient in BCLW, a death-protecting member of the BCL2 family, are sterile due to an arrest in spermatogenesis that is associated with a gradual loss of germ cells and Sertoli cells from the testis. As Bclw is expressed in both Sertoli cells and diploid male germ cells, it has been unclear which of these cell types requires BCLW in a cell-autonomous manner for survival. To determine whether death of Sertoli cells in Bclw mutants is influenced by the protracted loss of germ cells, we examined testes from Bclw/c-kit double mutant mice, which lack germ cells from birth. Loss of BCLW-deficient Sertoli cells occurs in the absence of germ cells, indicating that germ cell death is not required to mediate loss of Sertoli cells in BCLW-deficient mice. This suggests that Sertoli cells require BCLW in a cell-intrinsic manner for long-term survival. The loss of Sertoli cells in Bclw mutants commences shortly after Sertoli cells have become postmitotic. In situ hybridization analysis indicates that Bclw is expressed in Sertoli cells both before and after exit from mitosis. Therefore, Bclw-independent pathways promote the survival of undifferentiated, mitotic Sertoli cells. We show that BAX and BAK, two closely related death-promoting members of the BCL2 family, are expressed in Sertoli cells. To determine whether either BAX or BAK activity is required for Sertoli cell death in Bclw mutant animals, we analyzed survival of Sertoli cells in Bclw/Bax and Bclw/Bak double homozygous mutant mice. While mutation of Bak had no effect, ablation of Bax suppressed the loss of Sertoli cells in Bclw mutants. Thus, BCLW mediates survival of postmitotic Sertoli cells in the mouse by suppressing death-promoting activity of BAX.     

Recovery from sublethal and potentially lethal damage in an X-ray-sensitive CHO cell

It has been suggested that DNA strand breaks are the molecular lesions responsible for radiation-induced lethality and that their repair is the basis for the recovery of irradiated cells from sublethal and potentially lethal damage. EM9 is a Chinese hamster ovary cell line that is hypersensitive to killing by X rays and has been reported to have a defect in the rate of rejoining of DNA single-strand breaks. To establish the importance of DNA strand-break repair in cellular recovery from sublethal and potentially lethal X-ray damage, those two parameters, recovery from sublethal and potentially lethal damage, were studied in EM9 cells as well as in EM9's parental repair-proficient strain, AA8. As previously reported, EM9 is the more radiosensitive cell line, having a D0 of 0.98 Gy compared to a D0 of 1.56 Gy for AA8 cells. DNA alkaline elution studies suggest that EM9 cells repair DNA single-strand breaks at a slower rate than AA8 cells. Neutral elution analysis suggests that EM9 cells also repair DNA double-strand breaks more slowly than AA8 cells. All of these data are consistent with the hypothesis that DNA strand-break ligation is defective in EM9 cells and that this defect accounts for increased radiosensitivity. The kinetics and magnitude of recovery from sublethal and potentially lethal damage, however, were similar for both EM9 and AA8 cells. Six-hour recovery ratios for sublethal damage repair were found to be 2.47 for AA8 cells and 1.31 for EM9 cells. Twenty-four-hour recovery ratios for potentially lethal damage repair were 3.2 for AA8 and 3.3 for EM9 cells. Both measurements were made at approximately equitoxic doses. Thus, the defect in EM9 cells that confers radiosensitivity and affects DNA strand-break rejoining does not affect sublethal damage repair or potentially lethal damage repair.     

Tousled-like kinase regulates cytokine-mediated communication between cooperating cell types during collective border cell migration

Collective cell migration is emerging as a major contributor to normal development and disease. Collective movement of border cells in the Drosophila ovary requires cooperation between two distinct cell types: four to six migratory cells surrounding two immotile cells called polar cells. Polar cells secrete a cytokine, Unpaired (Upd), which activates JAK/STAT signaling in neighboring cells, stimulating their motility. Without Upd, migration fails, causing sterility. Ectopic Upd expression is sufficient to stimulate motility in otherwise immobile cells. Thus regulation of Upd is key. Here we report a limited RNAi screen for nuclear proteins required for border cell migration, which revealed that the gene encoding Tousled-like kinase (Tlk) is required in polar cells for Upd expression without affecting polar cell fate. In the absence of Tlk, fewer border cells are recruited and motility is impaired, similar to inhibition of JAK/STAT signaling. We further show that Tlk in polar cells is required for JAK/STAT activation in border cells. Genetic interactions further confirmed Tlk as a new regulator of Upd/JAK/STAT signaling. These findings shed light on the molecular mechanisms regulating the cooperation of motile and nonmotile cells during collective invasion, a phenomenon that may also drive metastatic cancer.     

Can mesenchymal cells undergo collective cell migration? The case of the neural crest

Cell migration is critical for proper development of the embryo and is also used by many cell types to perform their physiological function. For instance, cell migration is essential for immune cells to monitor the body and for epithelial cells to heal a wound whereas, in cancer cells, acquisition of migratory capabilities is a critical step towards malignancy. Migratory cells are often categorized into two groups: mesenchymal cells, produced by an epithelium-to-mesenchyme transition, that undergo solitary migration and epithelial-like cells which migrate collectively. However, on some occasions, mesenchymal cells may travel in large, dense groups and exhibit key features of collectively migrating cells such as coordination and cooperation. Here, using data published on Neural Crest cells, a highly invasive mesenchymal cell population that extensively migrate throughout the embryo, we explore the idea that other mesenchymal cells, including cancer cells, might be able to undergo collective cell migration under certain conditions and discuss how they could do so.     

Evaluation of cytotoxic properties of organometallic ferrocifens on melanocytes, primary and metastatic melanoma cell lines

Malignant melanoma is one of the most severe forms of skin cancer, and chemotherapeutic agents currently in use are poorly effective in curing the disease. Here we describe the properties of two organometallic ferrocenyl derivatives, ferrocifen (Fc-OH-Tam) and ferrociphenol (Fc-diOH) that show a specific antiproliferative effect on melanoma cells. After a short incubation period, Fc-OH-Tam is highly cytotoxic on melanoma cells but less toxic on melanocytes. Fc-diOH is slightly toxic at a high concentration but no discrepancy is observed between malignant and normal cells. After a long incubation time the latter is highly toxic for malignant cells but not for normal cells while the former was very highly toxic for primary malignant cells and significantly less toxic for normal cells. We also found that oxidative stress is not implicated in the mechanism of cytotoxicity, since both derivatives neither induce reactive oxygen species (ROS) level in melanocytes nor in melanoma cells. Finally, investigation on hair follicle growth revealed that the two organometallic derivatives induced an irreversible ejection of the hair shaft, thus predicting a potential hair loss side effect if used as a chemotherapeutic treatment.     

Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae

The major complication of reversal (or type 1) reactions in leprosy is peripheral nerve damage. The pathogenesis of nerve damage remains largely unresolved. In situ analyses suggest an important role for type 1 T cells. Mycobacterium leprae is known to have a remarkable tropism for Schwann cells that surround peripheral axons. Reversal reactions in leprosy are often accompanied by severe and irreversible nerve destruction and are associated with increased cellular immune reactivity against M. leprae. Thus, a likely immunopathogenic mechanism of Schwann cell and nerve damage in leprosy is that infected Schwann cells process and present antigens of M. Leprae to antigen-specific, inflammatory type 1 T cells and that these T cells subsequently damage and lyse infected Schwann cells. Previous studies using rodent CD8+ T cells and Schwann cells have revealed evidence for the existence of such a mechanism. Recently, a similar role has been suggested for human CD4+ T cells. These cells may be more important in causing leprosy nerve damage in vivo, given the predilection of M. leprae for Schwann cells and the dominant role of CD4+ serine esterase+ Th1 cells in leprosy lesions. Antagonism of molecular interactions between M. leprae, Schwann cells and inflammatory T cells may therefore provide a rational strategy to prevent Schwann cell and nerve damage in leprosy.